Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza

Secondary bacterial infections (SBIs) exacerbate influenza-associated disease and mortality. Antimicrobial agents can reduce the severity of SBIs, but many have limited efficacy or cause adverse effects. Thus, new treatment strategies are needed. Kinetic models describing the infection process can h...

Descripción completa

Detalles Bibliográficos
Autor principal: Smith, Amber M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376398/
https://www.ncbi.nlm.nih.gov/pubmed/27679506
http://dx.doi.org/10.1007/s10928-016-9494-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376398/
https://www.ncbi.nlm.nih.gov/pubmed/27679506
http://dx.doi.org/10.1007/s10928-016-9494-9

Ejemplares similares